Melgain (decapeptide) / Zydus Lifesciences - LARVOL DELTA

The Safety and Effectiveness of Decapeptide in Patients With Vitiligo: A Real-World Study. (PubMed, Cureus) - "Methods This retrospective analysis utilized data collected from routine clinical practice in the management of vitiligo, focusing on patients treated with topical decapeptide lotion (Melgain™, manufactured by Zydus Healthcare Ltd., Ahmedabad, India)...Both decapeptide regimens, as monotherapy or in combination with other therapies, were effective and well tolerated by most patients. Thus, decapeptide represents a safe and effective therapeutic option for vitiligo treatment."

Journal • Real-world • Real-world evidence • Dermatology • Immunology • Vitiligo • FGF

Urology Times Innovation Celebration: Expert Insights - Episode 27: Dr. Crawford on LHRH analogues in prostate cancer (Urology Times) - "n this interview, E. David Crawford, MD, discusses the development of luteinizing hormone-releasing hormone agonists and antagonists in prostate cancer."

Interview